HTG Molecular
HTG Molecular Diagnostics Q2 Revenues up 5 Percent as Pandemic Pressures Ease
The company said that it saw growing demand for RUO sample processing services and consumables as development activities among its customer base picked up speed.
HTG Molecular Diagnostics Q1 Revenues Drop 36 Percent
For the quarter ended March 31, the Tucson, Arizona-based firm's revenues fell to $1.4 million from $2.2 million a year ago.
HTG Molecular Preliminary Q1 Revenues Fall 56 Percent
For the three months ended March 31, the firm said that preliminary revenues for Q1 are expected to be $1.4 million compared with $3.2 million a year ago.
HTG Molecular Diagnostics FY 2020 Revenues Fall 56 Percent
For the year ended Dec. 31, 2020, the firm reported revenues of $8.5 million compared to $19.2 million in 2019, beating the Wall Street estimate of $8.3 million.
Nov 23, 2020
HTG Molecular Completes 1-For-15 Reverse Stock Split
Nov 11, 2020
Jun 26, 2020